Create account
Log in
Clinical Guidelines
Home
About
About the clinical guidelines
Declaring and dealing with competing interests
Frequently asked questions
Guideline journal articles
CCA guidelines
Barrett's Oesophagus
Bowel cancer
Colorectal cancer
Surveillance colonoscopy
Endometrial cancer
Cervical cancer screening
Lung cancer
Lung cancer prevention & diagnosis
Lung cancer treatment
Prostate cancer
Advanced prostate cancer
PSA testing
Sarcoma
Skin cancer
Melanoma
Keratinocyte cancer (non-melanoma)
Pain management
Archive of CCA guidelines
COSA guidelines
Adolescents and Young Adult (AYA) guidelines
AYA early cancer detection
AYA psychosocial management
Cancer therapy medication safety
Gastroenteropancreatic neuroendocrine tumours
Head & neck cancer nutrition
Teleoncology
Hosted
Childhood Brain Tumour or Leukaemia
National Cancer Prevention Policy
View
Code
History
Refresh
What links here
Related changes
User contributions
Logs
View user groups
Special pages
Permanent link
Page information
Browse properties
Assoc. Prof. Nick Pavlakis
From Cancer Guidelines Wiki
Jump to:
navigation
,
search
Affiliation
Royal North Shore Hospital, Sydney NSW
Role
Head, Department of Medical Oncology
Competing interest
This person has declared the following competing interest:
Lung Cancer Advisory Boards: Lilly, Merck-Sereno, Roche, Astra-Zeneca, Boehringer Ingelheim Speaking Honoraria: Lilly, Roche, Merck-Sereno, Pfizer, Boehringer Ingelheim
